1-6 of 6
Thomas Martin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD4 + CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy

Guy Ledergor, Zenghua Fan, Kai Wu, Elizabeth McCarthy, Axel Hyrenius-Wittsten, Alec Starzinski, Hewitt Chang, Mark Bridge, Serena Kwek, Alexander Cheung, Sophia Bylsma, Erik Hansen, Jeffrey Wolf, Sandy Wong, Nina Shah, Kole T. Roybal, Thomas Martin, Chun J. Ye, Lawrence Fong
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3562–3575.
https://doi.org/10.1182/bloodadvances.2023012416
Published: 2024
Includes: Supplemental data
Journal Articles

Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma

Clinical Trials & Observations
Kevin R. Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2207–2216.
https://doi.org/10.1182/bloodadvances.2023012066
Published: 2024
Includes: Supplemental data
Journal Articles

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma

Clinical Trials & Observations
Thomas Martin, Joseph Mikhael, Roman Hajek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatiana Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4506–4515.
https://doi.org/10.1182/bloodadvances.2021006713
Published: 2022
Journal Articles

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy

Swetha Kambhampati, Ying Sheng, Chiung-Yu Huang, Sophia Bylsma, Mimi Lo, Vanessa Kennedy, Kelsey Natsuhara, Thomas Martin, Jeffrey Wolf, Nina Shah, Sandy W. Wong
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2045–2054.
https://doi.org/10.1182/bloodadvances.2020004079
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma

Clinical Trials & Observations
Joaquin Martinez-Lopez, Sandy W. Wong, Nina Shah, Natasha Bahri, Kaili Zhou, Ying Sheng, Chiung-Yu Huang, Thomas Martin, Jeffrey Wolf
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3295–3301.
https://doi.org/10.1182/bloodadvances.2020002037
Published: 2020
Journal Articles

Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma

Clinical Trials & Observations
Rafael Alonso, María-Teresa Cedena, Sandy Wong, Nina Shah, Rafael Ríos-Tamayo, José M. Moraleda, Javier López-Jiménez, Cristina García, Natasha Bahri, Antonio Valeri, Ricardo Sánchez, Luis Collado-Yurrita, Thomas Martin, Jeffrey Wolf, Juan-José Lahuerta, Joaquín Martínez-López
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2163–2171.
https://doi.org/10.1182/bloodadvances.2020001508
Published: 2020